Catatonia: Back to the future of the neuropsychiatric syndrome

Cuevas‐Esteban, Jorge; Sanagustin, David; Iglesias-González, María

doi:10.1016/j.medcle.2022.03.005

Cited by 6 publications

(6 citation statements)

References 50 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In epidemiological studies, the incidence of catatonia in adult inpatients with psychiatric conditions was estimated to be approximately 10%[ 43 - 45 ]. However, the prevalence of catatonia varied substantially based on underlying or comorbid conditions, ranging from 4% to 67% in schizophrenia, from 14% to 71% in mood disorders, from 4% to 46% in medical conditions[ 46 ], and from 6% to 20.2% in neurodevelopmental disabilities[ 47 ].…”

Section: Research Developments In the Field Of Catatoniamentioning

confidence: 99%

First 150 years of catatonia: Looking back at its complicated history and forward to the road ahead

Csihi,

Ungvari,

Caroff

et al. 2024

World J Psychiatry

View full text Add to dashboard Cite

Karl Ludwig Kahlbaum (1828-1899) was the first to conceptualize and describe the main clinical features of a novel psychiatric illness, which he termed catatonia in his groundbreaking monograph published 150 years ago. Although Kahlbaum postulated catatonia as a separate disease entity characterized by psychomotor symptoms and a cyclical course, a close examination of his 26 cases reveals that most of them presented with motor symptom complexes or syndromes associated with various psychiatric and medical conditions. In his classification system, Kraepelin categorized catatonic motor symptoms that occur in combination with psychotic symptoms and typically have a poor prognosis within his dementia praecox (schizophrenia) disease entity. Because of the substantial influence of Kraepelin’s classification, catatonia was predominantly perceived as a component of schizophrenia for most of the 20th century. However, with the advent of the psychopharmacotherapy era starting from the early 1950s, interest in catatonia in both clinical practice and research subsided until the early 2000s. The past two decades have witnessed a resurgence of interest in catatonia. The Diagnostic and Statistical Manual of Mental Disorders Fifth Edition, marked a paradigmatic shift by acknowledging that catatonia can occur secondary to various psychiatric and medical conditions. The introduction of an independent diagnostic category termed “Catatonia Not Otherwise Specified” significantly stimulated research in this field. The authors briefly review the history and findings of recent catatonia research and highlight promising directions for future exploration.

show abstract

Section: Research Developments In the Field Of Catatoniamentioning

confidence: 99%

First 150 years of catatonia: Looking back at its complicated history and forward to the road ahead

Csihi,

Ungvari,

Caroff

et al. 2024

World J Psychiatry

View full text Add to dashboard Cite

show abstract

“… Source: Arnts et al (2020), Cuevas-Esteban et al (2022), Denysenko et al (2018), Harten et al (1999), Ishizuka et al (2022), Morrison (2006), Oldham and Lee (2015), Rasmussen et al (2016), Taylor and Fink (2003), Wang and Rehman (2021), Wong (2010). NCSE: non-convulsive status epilepticus; NMS: neuroleptic malignant syndrome; SS: serotonin syndrome. …”

Section: Clinical Assessmentmentioning

confidence: 99%

Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology

et al. 2023

View full text Add to dashboard Cite

The British Association for Psychopharmacology developed an evidence-based consensus guideline on the management of catatonia. A group of international experts from a wide range of disciplines was assembled. Evidence was gathered from existing systematic reviews and the primary literature. Recommendations were made on the basis of this evidence and were graded in terms of their strength. The guideline initially covers the diagnosis, aetiology, clinical features and descriptive epidemiology of catatonia. Clinical assessments, including history, physical examination and investigations are then considered. Treatment with benzodiazepines, electroconvulsive therapy and other pharmacological and neuromodulatory therapies is covered. Special regard is given to periodic catatonia, malignant catatonia, neuroleptic malignant syndrome and antipsychotic-induced catatonia. There is attention to the needs of particular groups, namely children and adolescents, older adults, women in the perinatal period, people with autism spectrum disorder and those with certain medical conditions. Clinical trials were uncommon, and the recommendations in this guideline are mainly informed by small observational studies, case series and case reports, which highlights the need for randomised controlled trials and prospective cohort studies in this area.

show abstract

“…The outbreak of catatonia is usually acute, in a matter of hours or days, resulting in frequent use of the emergency departments and hospitalisation. However, in schizophrenia, the syndrome may have a subacute onset and a tendency to become chronic [123].…”

Section: Psychomotor Disturbancesmentioning

confidence: 99%

New Directions for Symptoms and Diagnosis in Schizophrenia

Crecan-Suciu¹,

Paunescu²

2023

Schizophrenia - Recent Advances and Patient-Centered Treatment Perspectives

View full text Add to dashboard Cite

Schizophrenia represents one challenging mental disorder from all the psychotic spectrum, considered to be a major health problem worldwide and because of the characteristic symptoms, the diagnosis is associated with high levels of stigmatization. It is quite common that the first acute symptoms to occur in early adult life and cause severe distress not only to the patient in need but also to their families. The schizophrenia clinical picture is usually misunderstood by the general public and consists of positive symptoms, negative symptoms, disorganized speech or behavior during a specific amount of time. In order to establish an accurate diagnosis, it requires taking into consideration both international classification systems, Diagnostic and Statistical Manual of Mental Disorders (DSM-5) and The International Classification of diseases (ICD-10), adding a fresh perspective to the newest chapter of ICD-11 called “Schizophrenia or other primary psychotic disorders”, alongside with the diagnosis criteria, other new symptoms such as cognitive impairment emerge as an important feature of schizophrenia.

show abstract

Catatonia: Back to the future of the neuropsychiatric syndrome

Cited by 6 publications

References 50 publications

First 150 years of catatonia: Looking back at its complicated history and forward to the road ahead

First 150 years of catatonia: Looking back at its complicated history and forward to the road ahead

Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology

New Directions for Symptoms and Diagnosis in Schizophrenia

Contact Info

Product

Resources

About